For Outstanding Contributions to Neuropsychopharmacology

Sponsored by Eli Lilly Canada Inc.

The Heinz Lehmann Award is designed to recognize outstanding contributions by a single individual in the field of research in neuropsychopharmacology in Canada. The Award consists of $5,000 research prize, a $2,000 travel award for the recipient to attend the CCNP Annual Meeting and a suitably engraved plaque. The Heinz Lehmann Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in the view of the Awards Committee, no qualified nominee.

Eligibility shall include individuals from academic institutions, foundations, governmental, industrial and research organizations, regardless of age or sex. The decision of the Awards Committee shall be based on originality and uniqueness of approach to clinical or laboratory research that had led to new, significant neuropsychopharmacological knowledge of concepts, or to the development of new therapeutic agents for the treatment of mental diseases. This should be evidenced by contributions based either on a specific piece of research or on a large body of neuropsychopharmacological research done over a period of years. The Awardee is expected to give a lecture based on his/her research at the Annual Meeting of the CCNP, and to contribute a manuscript, based on the lecture, to the CCNP official journal, the Journal of Psychiatry & Neuroscience, no later than six months after the lecture.

2010 Heinz Lehmann Award Winner

Congratulations to Dr. Pierre Blier, the winner of the 2010 Heinz Lehmann Award. Read Dr. Pierre Blier's biography.

See the previous recipients of this award here.